Cancer BiologybioRxivPreprint
AXL mediates mast cell survival and resistance to tyrosine kinase inhibitors in mastocytosis
Kitsada Kangboonruang, Philippe Drabent, Fatlinda Maksut…·Leïla Maouche-Chrétien
This study identifies AXL as a driver of mast cell survival and TKI resistance in mastocytosis and shows that dual KIT/AXL inhibition restores TKI sensitivity.
DOI 10.1101/2025.11.03.686205